Hydroxychloroquine Market Size, Share & Growth Report 2032
Hydroxychloroquine Market By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, And Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, And Others), And By Region - Global Industry Perspective, Comprehensive Analysis, And Forecast, 2024 – 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 941.1 Million | USD 1,405.60 Million | 4.68% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Hydroxychloroquine Market, 2024–2032 (USD Million)
- 2.2. Hydroxychloroquine Market: Snapshot
- Chapter 3. Global Hydroxychloroquine Market– Industry Analysis
- 3.1. Hydroxychloroquine Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Anti-viral characteristics of the drug and ability to change immune system activity will drive the business landscape
- 3.2.2. Beneficial features such as lower side effects and toxicity will enlarge the market scope over the forecast period
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Type
- 3.4.2. Market attractiveness analysis By Application
- Chapter 4. Global Hydroxychloroquine Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Hydroxychloroquine Market: company market share, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Hydroxychloroquine Market–Type Analysis
- 5.1. Global Hydroxychloroquine Market overview: By Type
- 5.1.1. Global Hydroxychloroquine Market share, By Type,2024 and 2032
- 5.2. USP Standards Grade
- 5.2.1. Global Hydroxychloroquine Market by USP Standards Grade, 2024–2032 (USD Million)
- 5.3. Pharmaceutical Standards Grade
- 5.3.1. Global Hydroxychloroquine Market by Pharmaceutical Standards Grade, 2024–2032 (USD Million)
- 5.4. EP Standards Grade
- 5.4.1. Global Hydroxychloroquine Market by EP Standards Grade, 2024–2032 (USD Million)
- 5.5. Others
- 5.5.1. Global Hydroxychloroquine Market by Others, 2024–2032 (USD Million)
- 5.1. Global Hydroxychloroquine Market overview: By Type
- Chapter 6. Global Hydroxychloroquine Market– Application Analysis
- 6.1. Global Hydroxychloroquine Market overview: By Application
- 6.1.1. Global Hydroxychloroquine Market share, By Application, 2024 and 2032
- 6.2. Rheumatoid Arthritis
- 6.2.1. Global Hydroxychloroquine Market By Rheumatoid Arthritis, 2024–2032 (USD Million)
- 6.3. Skin Lesions
- 6.3.1. Global Hydroxychloroquine Market By Skin Lesions, 2024–2032 (USD Million)
- 6.4. Systemic Lupus Erythematosus
- 6.4.1. Global Hydroxychloroquine Market By Systemic Lupus Erythematosus, 2024–2032 (USD Million)
- 6.5. Chronic Discoid Lupus Erythematosus
- 6.5.1. Global Hydroxychloroquine Market By Chronic Discoid Lupus Erythematosus, 2024–2032 (USD Million)
- 6.6. Others
- 6.6.1. Global Hydroxychloroquine Market By Others, 2024–2032 (USD Million)
- 6.1. Global Hydroxychloroquine Market overview: By Application
- Chapter 7. Company Profiles
- 7.1. Teva
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Mylan
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Novartis
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Cadila Healthcare
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Torrent Pharma
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Shanghai Zhongxisanwei
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. BSE healthcare
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. Sandoz
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Product Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. HIKMA
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Product Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. IPCA Laboratories
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Product Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Cipla Limited
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Product Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. Shanghai Pharma
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Product Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Intas Pharmaceuticals
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Product Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. Lupin Limited
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Product Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. Shenhua Pharm
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Product Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.16. Sanofi
- 7.16.1. Overview
- 7.16.2. Financials
- 7.16.3. Product Portfolio
- 7.16.4. Business Strategy
- 7.16.5. Recent Development
- 7.17. H-QYN
- 7.17.1. Overview
- 7.17.2. Financials
- 7.17.3. Product Portfolio
- 7.17.4. Business Strategy
- 7.17.5. Recent Development
- 7.18. H-QYN
- 7.18.1. Overview
- 7.18.2. Financials
- 7.18.3. Product Portfolio
- 7.18.4. Business Strategy
- 7.19. Macleod Pharmaceuticals
- 7.19.1. Overview
- 7.19.2. Financials
- 7.19.3. Product Portfolio
- 7.19.4. Business Strategy
- 7.20. McW Healthcare
- 7.20.1. Overview
- 7.20.2. Financials
- 7.20.3. Product Portfolio
- 7.20.4. Business Strategy
- 7.20.5. Recent Development
- 7.21. Laurus Labs
- 7.21.1. Overview
- 7.21.2. Financials
- 7.21.3. Product Portfolio
- 7.21.4. Business Strategy
- 7.21.5. Recent Development
- 7.22. TAJ Pharma
- 7.22.1. Overview
- 7.22.2. Financials
- 7.22.3. Product Portfolio
- 7.22.4. Business Strategy
- 7.22.5. Recent Development
- 7.23. Wuhan Wuyao Pharmaceutical
- 7.23.1. Overview
- 7.23.2. Financials
- 7.23.3. Product Portfolio
- 7.23.4. Business Strategy
- 7.23.5. Recent Development
- 7.24. MAAN Medex
- 7.24.1. Overview
- 7.24.2. Financials
- 7.24.3. Product Portfolio
- 7.24.4. Business Strategy
- 7.24.5. Recent Development
- 7.25. Cinkate
- 7.25.1. Overview
- 7.25.2. Financials
- 7.25.3. Product Portfolio
- 7.25.4. Business Strategy
- 7.25.5. Recent Development
- 7.26. Concordia Healthcare
- 7.26.1. Overview
- 7.26.2. Financials
- 7.26.3. Product Portfolio
- 7.26.4. Business Strategy
- 7.26.5. Recent Development
- 7.1. Teva
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Hydroxychloroquine Market, 2024–2032 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Hydroxychloroquine Market attractiveness, By Type
6. Global Hydroxychloroquine Market attractiveness, By Application
7. Global Hydroxychloroquine Market share, By Type, 2024 and 2032
8. Global Hydroxychloroquine Market by USP Standards Grade, 2024–2032 (USD Million)
9. Global Hydroxychloroquine Market by Pharmaceutical Standards Grade,2024–2032 (USD Million)
10. Global Hydroxychloroquine Market by EP Standards Grade,2024–2032 (USD Million)
11. Global Hydroxychloroquine Market by Others,2024–2032 (USD Million)
12. Global Hydroxychloroquine Market Share by Application,2024 and 2032 (USD Million)
13. Global Hydroxychloroquine Market by Rheumatoid Arthritis,2024–2032 (USD Million)
14. Global Hydroxychloroquine Market by Skin Lesions ,2024–2032 (USD Million)
15. Global Hydroxychloroquine Market by Systemic Lupus Erythematosus,,2024–2032 (USD Million)
16. Global Hydroxychloroquine Market by Chronic Discoid Lupus Erythematosus,2024–2032 (USD Million)
17. Global Hydroxychloroquine Market, By Others, 2024–2032 (USD Million)
18. Global Hydroxychloroquine Market share, by Region, 2024 and 2032
19. North America Hydroxychloroquine Market, 2024–2032 (USD Million)
20. Europe Hydroxychloroquine Market, 2024–2032 (USD Million)
21. Asia Pacific Hydroxychloroquine Market, 2024–2032 (USD Million)
22. Latin America Hydroxychloroquine Market, 2024–2032 (USD Million)
23. The Middle East and Africa Hydroxychloroquine Market, 2024–2032 (USD Million)
Table Of Tables
List of Tables
1. Global Hydroxychloroquine Market: snapshot
2. Drivers of the Hydroxychloroquine Market: impact analysis
3. North America Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
4. North America Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
5. The U.S. Hydroxychloroquine Market revenue, By Type, 2024–2032 (USD Million)
6. The U.S. Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
7. Rest of North America Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
8. Rest of North America Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
9. Europe Hydroxychloroquine Market revenue, By Type, 2024–2032 (USD Million)
10. Europe Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
11. UK Hydroxychloroquine Market revenue, By Type ,2024–2032 (USD Million)
12. UK Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
13. France Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
14. France Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
15. Germany Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
16. Germany Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
17. Rest of Europe Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
18. Rest of Europe Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
19. Asia Pacific Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
20. Asia Pacific Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
21. China Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
22. China Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
23. Japan Hydroxychloroquine Market revenue, By Type, 2024–2032 (USD Million)
24. Japan Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
25. India Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
26. India Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
27. Rest of Asia Pacific Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
28. Rest of Asia Pacific Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
29. Latin America Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
30. Latin America Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
31. Brazil Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
32. Brazil Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
33. Rest of Latin America Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
34. Rest of Latin America Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
35. The Middle East and Africa Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
36. The Middle East and Africa Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
37. Saudi Arabia Hydroxychloroquine Market revenue, By Type, 2024–2032 (USD Million)
38. Saudi Arabia Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
39. South Africa Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
40. South Africa Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
41. Rest of the Middle East & Africa Hydroxychloroquine Market revenue, By Type,2024–2032 (USD Million)
42. Rest of the Middle East & Africa Hydroxychloroquine Market revenue, By Application, 2024–2032 (USD Million)
Methodology
FrequentlyAsked Questions
Hydroxychloroquine is a medication that wears two hats in the medical world. Primarily, it's used to combat malaria. In areas where malaria is prevalent, hydroxychloroquine can be taken to prevent infection. It can also treat uncomplicated cases of malaria if the disease is already contracted.
According to a study, the global hydroxychloroquine market size was worth around USD 941.1 million in 2023 and is expected to reach USD 1,405.60 million by 2032.
The global hydroxychloroquine market is expected to grow at a CAGR of 4.68% during the forecast period.
Asia Pacific is expected to dominate the hydroxychloroquine market over the forecast period.
Leading players in the global hydroxychloroquine market include Teva, Mylan, Novartis, Cadila Healthcare, Torrent Pharma, Shanghai Zhongxisanwei, BSE Healthcare, Sandoz, HIKMA, IPCA Laboratories, Cipla Limited, Shanghai Pharma, Intas Pharmaceuticals, Lupin Limited, Shenhua Pharm, Sanofi, H-QYN, Macleod Pharmaceuticals, McW Healthcare, Laurus Labs, TAJ Pharma, Wuhan Wuyao Pharmaceutical, MAAN Medex, Cinkate, and Concordia Healthcare, among others.
The hydroxychloroquine market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed